Related Experiment Video
Updated: Jun 23, 2026

An Allelotyping PCR for Identifying Salmonella enterica serovars Enteritidis, Hadar, Heidelberg, and Typhimurium
Published on: July 22, 2011
Clinical and Antimicrobial Resistance Patterns of Salmonella enterica Serovar Paratyphi A Infections in Pediatric
Surendra Bahadur Mathur1, Dharmendra Kumar Singh2, Naz Perween3
1Department of Pediatrics, Postgraduate Institute of Child Health, Sector - 30, Gautam Buddha Nagar, Noida, Uttar Pradesh, India. sbmathur05@gmail.com.
Insights
Pediatric Salmonella Paratyphi A infections show emerging resistance to common antibiotics like ceftriaxone. However, children responded well to tailored antimicrobial therapy, indicating favorable short-term outcomes despite resistance patterns.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Resistance
- Bacteriology
Background:
- Salmonella enterica serovar Paratyphi A (SPA) infections pose a significant public health concern in children.
- Understanding the clinical and microbiological characteristics of SPA is crucial for effective management.
Purpose of the Study:
- To analyze the clinical profiles of pediatric SPA infections.
- To determine antibiotic susceptibility patterns and biochemical characteristics of SPA isolates in children.
Main Methods:
- Retrospective observational study of hospitalized pediatric patients (<18 years) with blood culture-confirmed SPA infection.
- Data collection included demographics, clinical features, treatment, antibiotic susceptibility, and outcomes.
- Statistical analysis performed using SPSS (P<0.05 significance).
Main Results:
- Forty-five pediatric cases analyzed; mean age 7 years.
- Fever, vomiting, and abdominal pain were common clinical signs.
- Significant resistance observed to ceftriaxone (31%) and fluoroquinolones (85-100%).
- High susceptibility noted for trimethoprim+sulfamethoxazole (100%) and chloramphenicol (90.6%).
- Extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase production detected in 35.6% and 26.7% of isolates, respectively.
Conclusions:
- Emerging antimicrobial resistance in pediatric SPA isolates is a growing concern.
- Short-term clinical outcomes were favorable with appropriate antimicrobial therapy.
- Tailored treatment strategies are essential for managing pediatric SPA infections effectively.
Objective:
This study aimed to analyze the clinical profiles, antibiotic susceptibility patterns and biochemical characteristics of Salmonella enterica serovar Paratyphi A (SPA) infections in children.
Methods:
A retrospective observational study was conducted on hospitalized pediatric patients (< 18 years) admitted with blood culture-confirmed SPA infection between January 2022 and October 2024. Data on demographics, clinical features, treatment regimens, antibiotic susceptibility and outcomes were extracted from medical records. Statistical analyses were performed using SPSS, with P < 0.05 considered significant.
Results:
Forty-five cases were included, with a mean (SD) age of 7 (4.3) years. Fever was universal (100%), accompanied by vomiting (46.7%) and abdominal pain (44.4%). Hepatomegaly and splenomegaly were observed in 46.7 and 42.2% of the cases, respectively. Third-generation cephalosporins were the most commonly used antibiotics (95.6%), but resistance to ceftriaxone was significant (31%). Fluoroquinolone resistance was found in 85-100% of the isolates. Trimethoprim + sulfamethoxazole (100%) and chloramphenicol (90.6%) exhibited the highest susceptibilities. Extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase production were detected in 35.6% and 26.7% of isolates, respectively.
Conclusion:
Emerging antimicrobial resistance was observed among pediatric SPA isolates; however, short-term clinical outcomes were favorable, with good response to appropriately tailored antimicrobial therapy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Reservoir of Infection
Clinical Significance of Antibiotic Resistance
